Bill and Melinda Gates Foundation donations made to The Scripps Research Institute

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United States
Wikipedia pagehttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Best overview URLhttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Facebook username gatesfoundation
LinkedIn username bill-&-melinda-gates-foundation
Websitehttps://www.gatesfoundation.org/
Donations URLhttps://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database
Twitter usernamegatesfoundation
Page on philosophy informing donationshttps://www.gatesfoundation.org/What-We-Do
Grant application process pagehttps://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ
Regularity with which donor updates donations datacontinuous updates
Regularity with which Donations List Website updates donations data (after donor update)irregular
Lag with which donor updates donations datamonths
Lag with which Donations List Website updates donations data (after donor update)years
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing

Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett

Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief

Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database

Full donor page for donor Bill and Melinda Gates Foundation

Basic donee information

ItemValue
Country
Facebook page ScrippsResearchInstitute
Websitehttp://www.scripps.edu
Twitter usernamescrippsresearch
Wikipedia pagehttps://en.wikipedia.org/wiki/Scripps_Research_Institute

Full donee page for donee The Scripps Research Institute

Donor–donee relationship

Item Value

Donor–donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 16 864,700 2,133,524 -2,254,000 263,357 316,096 327,377 710,300 864,700 2,351,662 3,000,000 3,342,614 4,997,674 12,066,128
Global health 16 864,700 2,133,524 -2,254,000 263,357 316,096 327,377 710,300 864,700 2,351,662 3,000,000 3,342,614 4,997,674 12,066,128

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2018 2017 2016 2015 2014
Global health (filter this donor) 16 34,136,389.23 -1,599,246.00 18,928,644.23 3,378,058.00 10,428,933.00 3,000,000.00
Total 16 34,136,389.23 -1,599,246.00 18,928,644.23 3,378,058.00 10,428,933.00 3,000,000.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of documents in reverse chronological order (0 documents)

There are no documents associated with this combination of donor and donee.

Full list of donations in reverse chronological order (16 donations)

Graph of all donations (with known year of donation), showing the timeframe of donations

Graph of donations and their timeframes
Amount (current USD)Amount rank (out of 16)Donation dateCause areaURLInfluencerNotes
327,377.00112018-10-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the discovery and early development of novel therapeutic agents against cryptosporidiosis and malaria; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
327,377.00112018-10-17Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to support the discovery and early development of novel therapeutic agents against cryptosporidiosis and malaria; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-2,254,000.00162018-07-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support late preclinical and early clinical development of a novel treatment for cryptosporidiosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,993,188.0062017-11-20Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to fund the development of cell therapies/vaccines to enable long-term antibody based immunity to HIV and other normally antibody resistant pathogens of global concern for which no effective vaccines exists; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
12,066,128.2312017-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to make progress towards influenza and malaria vaccines that will be of great benefit for global health; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
3,342,614.0042017-11-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support late preclinical and early clinical development of a novel treatment for cryptosporidiosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
263,357.00142017-10-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the discovery and early development of novel therapeutic agents against cryptosporidiosis and malaria; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
263,357.00142017-10-16Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to support the discovery and early development of novel therapeutic agents against cryptosporidiosis and malaria; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,351,662.0072016-11-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support late preclinical and early clinical development of a novel treatment for cryptosporidiosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
316,096.00132016-10-27Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to define the molecular signature of effective germinal center dynamics in order to optimize timing, antigen format and memory T cell help in ways that can be rapidly utilized to assess effective vaccine strategies; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
710,300.00102016-04-08Global health/malariahttps://iatiregistry.org/publisher/bmgf-- To support general operating costs for work on structure-based immunogen design of a Pfs25 transmission-blocking vaccine for falciparum malaria; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
4,997,674.0022015-09-18Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to evaluate the feasibility of passive protection using a novel entry inhibitor, eCD4-Ig, to prevent HIV-1 infection; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
864,700.0092015-09-16Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide general operating support. Gen Ops Support - GC: Preventing HIV-1 transmission with a novel entry inhibitor, eCD4-Ig. Investment start date: 9/16/2015 to end date: 7/31/2020. Grantee name: The Scripps Research Institute; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
1,015,629.0082015-06-01Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide general operating support to TSRI to support a variety of scientific research and purchase of a Titan Krios electron microscope will be used to solve cryo-EM structures of HIV-1 immunogens to guide rational vaccine design efforts; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
3,550,930.0032015-06-01Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to accelerate HIV-1 vaccine research to help identify the best vaccine candidates for HIV-1 eradication; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
3,000,000.0052014-04-04Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide general operating support to TSRI to support a variety of scientific research and purchase of a Titan Krios electron microscope will be used to solve cryo-EM structures of HIV-1 immunogens to guide rational vaccine design efforts; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.